Current stock page

Stock Analysis

uniQure N.V. (QURE) Stock Analysis

uniQure N.V. (QURE) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.

QURE Stock Analysis Summary

uniQure N.V. (QURE) currently has an AIQ Score of 39/100, indicating a bearish setup. Quality is the strongest factor at 42/100. Risk is the weakest current factor at 31/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.

Updated Nov 13, 2026 · Market-close data

QURE at a Glance

Crawlable current metrics from the latest market-close stock snapshot.

MetricCurrent
Price$23.81
AIQ Score39/100
Overall ViewBearish
Technical Analysis ConsensusNeutral
Market Cap$1.66B
P/E Ratio (TTM)-6.73
Forward P/E—
EPS (Q3 FY2026)-$0.88
Revenue (Q3 FY2026)$5.2M
Dividend Yield (TTM)0.00%
Beta0.68
Volume1.39M
52-week range$8.73-$51.72
RSI 1445.74
50-Day SMA$29.50
200-Day SMA$29.64
Analyst Price Target$50.17
Next EarningsMar 1, 2027
As of Nov 13, 2026 · Market close

QUREuniQure N.V.

Healthcare / Biotechnology

Low Priority

Relative Laggard

BearishEdge 2/10
$23.81−$0.82 (−3.33%)

Latest quote

  • Momentum
    41
  • Value
    38
  • Quality
    42
  • Risk resilience
    31
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

QURE Stock Analysis Summary

uniQure N.V. (QURE) currently has an AIQ Score of 39/100, indicating a bearish setup. Quality is the strongest factor at 42/100. Risk resilience is the weakest current factor at 31/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.

Updated Nov 13, 2026 · Market-close data
AIQ Composite Posture: Bearish

In a bearish regime, QURE has AIQ Score of 39/100 with Quality base of 42/100 and fading Risk resilience at 31/100. Wait for component alignment before adding exposure.

Healthcare · -3.33% stock move · QURE classified in Biotechnology.

Current Evidence

BearishQURE is in a bearish AIQ regime; Quality is the strongest visible factor at 42/100.
Core coverage reflects visible evidence only

AlgovestIQ Evidence Summary

Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.

Is QURE Bullish or Bearish Right Now?

QURE currently has a bearish overall setup. Quality is the strongest factor at 42/100, while Risk Resilience is weakest at 31/100. The current evidence suggests a bearish setup.

Bull Case
  • - Analyst target implies +110.70% upside from the latest quote.
  • - Technical consensus has more buy votes than sell votes (22 vs 17).
Bear Case
  • - Value is the current constraint at 38/100.
  • - Momentum is weak at 41/100.
  • - Risk Resilience is weak at 31/100.
  • - Price is -19.68% below its 200-day SMA.

Current Consensus

QURE's Technical Analysis Consensus is currently Neutral, with 22 buy, 7 neutral, and 17 sell votes. QURE's 14-day RSI is 45.74, which places the stock in a neutral momentum range. QURE's beta is 0.68, indicating lower market sensitivity than the broad market.

Signal Confidence
Moderate agreement

What Changed in QURE?

The largest recent change in QURE is Momentum moving down by 4.0 points over the available 7-day comparison window. Quality remains the strongest visible factor.

AIQ Score
-1.0
Momentum
-4.0
Quality
+4.0
Risk
-1.0

What Would Change the QURE Outlook?

The current bearish outlook could improve if AIQ reaches 65 (Bullish), momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 50 (Bearish), price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.

Bullish confirmation

AIQ 65+ (Bullish), RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.

Bearish deterioration

AIQ below 50 (Bearish), RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.

QURE Decision Framework

Public evidence layers, setup checks, and risk context for uniQure N.V..

uniQure N.V. (QURE) Stock Analysis

uniQure N.V. has an AIQ Score of 39/100 in a Bearish regime. Quality is strongest at 42/100. Beta is 0.68, below market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.

Evidence LayerPublic Evidence
Regime ContextQURE is in a Bearish AIQ regime with score 39/100.
Signal ConflictThe primary conflict is that quality leads at 42/100 while risk lags at 31/100.
Factor EvidenceMomentum 41/100 · Value 38/100 · Quality 42/100 · Risk 31/100
PersistenceCurrent snapshot evidence is shown; historical persistence remains in AIQ Pro.

Current Setup Checklist

Factor strengthFail

Quality is the strongest factor at 42/100.

TimingFail

Momentum is 41/100 and RSI (14) is 45.7.

Regime fitFail

QURE is in a Bearish regime at 39/100.

Risk controlFail

Risk factor is 31/100 with beta 0.68 and annual volatility 132.25%.

ConflictPass

Current conflict: quality leads at 42/100 while risk lags at 31/100.

AIQ Score
39/100
Price
$23.81
Beta
0.68
RSI (14)
45.7

QURE Research Cluster

Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.

QURE Fundamentals

QURE valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.

Revenue
$5.2M
Net income
-$61.22M
Free cash flow
-$47.84M
View full QURE fundamental analysis

QURE Technical Analysis

QURE technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.

Technical Analysis Consensus
Neutral
RSI 14
45.74
Price vs SMA-50
-19.29%
View full QURE technical analysis

QURE Stock Catalysts

Track QURE earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.

Next earnings
Mar 1, 2027
Analyst target
$50.17
News items
5
View QURE earnings and stock catalysts

QURE Dividend Analysis

QURE dividend yield, annual dividend, payout ratio, payment history, and income reliability context.

Dividend yield
0.00%
Annual dividend
—
Payout ratio
—
View QURE dividend history and analysis

QURE Financial Data

QURE revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.

Quarter revenue
$5.2M
EPS
-$0.88
Periods
8
View QURE financials

QURE Risk Analysis

QURE volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.

Beta
0.68
Risk score
31/100
1Y volatility
132.25%
View QURE risk analysis

QURE Stock News

QURE stock news, market tone, recent headlines, and catalyst context.

News items
5
Updated
Nov 15, 2026
Sentiment
—
Read QURE stock news

QURE vs Biotechnology Peers

Current peer cohort: QURE · RAPP · RCUS · REPL · RLAY. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.

PeerAIQValueMomentumRiskSharpe1Y VolatilityCompare
QURE
Current stock
39/10038/10041/10031/1000.39132.25%Current
RAPP
Rapport Therapeutics, Inc. Common Stock
43/10042/10033/10039/1000.3562.34%QURE vs RAPP
RCUS
Arcus Biosciences, Inc.
39/10043/10034/10042/1000.0562.65%QURE vs RCUS
REPL
Replimune Group, Inc.
60/100—97/10026/1001.3187.93%QURE vs REPL
RLAY
Relay Therapeutics, Inc.
56/10037/10076/10052/1001.8465.80%QURE vs RLAY
Pairwise Compare links: RAPP · RCUS · REPL · RLAYQURE vs RAPPQURE vs RCUSQURE vs REPLQURE vs RLAYCompare cohort

Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Nov 13, 2026.

About the AIQ Score

Methodology for the current stock evidence.

As of Nov 13, 2026 · Market close

The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.

View AIQ methodology

Factor Diagnostics

A compact bridge from the AIQ score to the evidence tabs.

Calculator
Calculate a QURE stock return scenario

Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.

Calculate stock return

Also for QURE: historical return with reinvested dividends and stock average calculator for several buys.

AIQ Component Profile

Compare the five component scores on one consistent 0–100 scale.

Catalyst preview

Review earnings timing, revisions, news pressure, and prior event reactions in one place.

Open catalysts
Quarterly evidence

8 recent quarterly periods are available for review.

Checked Nov 16, 2026

AIQ Pro

Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.

Fundamentals Verdict

Current snapshot fields are separate from reported-quarter statement tables.

Current TTM P/E
-6.73
As of Nov 13, 2026
Revenue growth
40.39%
Gross margin
29.32%
Current debt / equity
0.21
Latest quarterly evidence

Latest period Sep 30, 2026.

Review fundamentals
Quarter revenue
$5.2M
Quarter net income
-$61.22M
Quarter free cash flow
-$47.84M

Market Confirmation

Technicals are summarized first, with the indicator library behind it.

Trend
Bearish
Momentum
Mixed
RSI 14
45.74
MACD
-1.23

Risk Alignment

Higher resilience is stronger; exposure metrics stay separate.

Resilience
31/100
Beta
0.68
Annual volatility
132.25%
Max drawdown
-70.24%

QURE Stock FAQ

What is QURE stock price today?

uniQure N.V.'s current stock price is $23.81. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.

Is QURE bullish or bearish right now?

QURE's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.

What is QURE's market cap?

QURE's market cap is $1.66B based on the latest completed market-close snapshot from Nov 13, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.

What is QURE's current P/E ratio?

QURE's current P/E ratio is -6.73 based on the latest completed market-close snapshot from Nov 13, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.

What is QURE's RSI?

QURE's 14-day RSI is 45.74 based on the latest completed market-close snapshot from Nov 13, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.

Is QURE above its 50-day and 200-day moving averages?

QURE is -19.29% from its 50-day SMA and -19.68% from its 200-day SMA based on the latest completed market-close snapshot from Nov 13, 2026. Moving-average position should be read with momentum and broader AIQ evidence.

When is QURE's next earnings date?

QURE's next earnings date is currently listed as Mar 1, 2027. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.

Does QURE pay a dividend?

QURE's dividend yield is 0.00% based on the latest completed market-close snapshot from Nov 13, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.